Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2005
10/13/2005US20050226871 Using mixture of fk-506 and geldanamycin compound immobilized onto polypeptide; both compounds bind to polypeptide components of steroid receptor complexes, hsp90 and FKBP52, respectively
10/13/2005US20050226870 Administering anti-inflammatory amount of a purified antibody specific against C5, wherein antibody inhibits the cleavage of C5 into C5a and C5b
10/13/2005US20050226856 Autogenic living scaffolds and living tissue matrices: methods and uses thereof
10/13/2005US20050226855 Transformation of pluripotential stem cells for tissue repain, replacement in organs such as heart, brain, liver, kidney or pancreas; supplying cells using catheters
10/13/2005US20050226854 treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof by transplanting into the subject tissue derived from a human or porcine kidney or liver, the kidney or liver being at a selected gestational stage
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005DE10393729T5 Verfahren zur Behandlung von Emesis A method of treating emesis
10/13/2005DE102004010967A1 Multielemantare Nanoculster und nanoskalige Multikomponenten Mineralstoff- und Spurenelementpräparate, sowie ein Verfahren zur Herstellung von nanoskaligen Multikomponenten Multielemantare Nanoculster and nanoscale multicomponent mineral and trace element preparations, and a method for producing nanoscale multi-component
10/13/2005CA2575740A1 Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods
10/13/2005CA2564643A1 Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists
10/13/2005CA2561530A1 Therapeutic or prophylactic agent for arthritis
10/13/2005CA2561383A1 Prophylactic and/or therapeutic agents for chronic musculoskeletal pain
10/13/2005CA2561380A1 A composition containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity
10/13/2005CA2560826A1 Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
10/13/2005CA2558607A1 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
10/13/2005CA2557999A1 Methods and compositions for treatment of ion imbalances
10/13/2005CA2557998A1 Combination therapy for weight management
10/12/2005EP1584682A1 Regulation of bcl-2 gene expression
10/12/2005EP1583747A2 Inhibitors of phosphatases
10/12/2005EP1583735A2 Novel aminobenzophenone compounds
10/12/2005EP1583559A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
10/12/2005EP1583542A1 Compositions and methods for combination antiviral therapy
10/12/2005EP1583522A1 Use of cyclin d1 inhibitors
10/12/2005EP1583504A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1583423A2 Intradermal cellular delivery using narrow gauge micro-cannula
10/12/2005EP1583422A2 Cell-based therapies for ischemia
10/12/2005EP1478362B1 A combination treatment for acute myocardial infarction
10/12/2005EP1335747A4 A composition of sodium channel blocking compound
10/12/2005EP1313485B1 Use of an aldosterone receptor antagonist to improve cognitive function
10/12/2005EP1272666B1 A functional assay of high-density lipoprotein
10/12/2005EP1242096B1 Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium
10/12/2005EP1231886A4 Topical skin composition
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1185249B1 Use of a biodegradable polymer
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1137414B1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
10/12/2005EP1100787B1 Lipid-lowering quinazoline derivative
10/12/2005EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/12/2005EP0904094B1 Treatment of bone disorders with adrenomedullin
10/12/2005EP0814842B1 Method for treating amyloidosis
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681941A Methods for the treatment of dementia based on APOE genotype
10/12/2005CN1681920A Modified ADMTS4 molecules and method of use thereof
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681791A 8－羟基喹啉衍生物 8-hydroxyquinoline derivative
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681533A Medicinal composition for treating arteriosclerosis
10/12/2005CN1681532A Therapeutics for diabetes mellitus
10/12/2005CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
10/12/2005CN1681518A Combination therapies with L-FMAU for the treatment of hepatitis b virus infection
10/12/2005CN1681517A Peptide boronic acids useful in making salts thereof
10/12/2005CN1681515A Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor
10/12/2005CN1681513A Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
10/12/2005CN1681512A Treatment of basal ganglia-related movement disorders with 2, 3-benzodiazepines
10/12/2005CN1681511A Combinations of drugs for the treatment of neoplasms
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681500A Topical treatment of skin diseases
10/12/2005CN1681496A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/12/2005CN1681492A Combinations of atorvastatin and alpha1adrenergic receptor antagonists
10/12/2005CN1680603A ANGPTL4/FIAF as marker for PPAR delta modulation
10/12/2005CN1680434A Streptococcus pneumoniae antigens
10/12/2005CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent
10/12/2005CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/12/2005CN1680341A Valsartan salts
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1679956A Treatment of androgen-deprivation induced osteoporosis
10/12/2005CN1679955A Compositions for improving drug safety
10/12/2005CN1679954A Compound preparation of calcium antagonist and timishatan for reducing blood pressure and its use
10/12/2005CN1679953A Pharmaceutical composition for regulating lipid concentration
10/12/2005CN1679952A Anticarcinogenic medicine composition
10/12/2005CN1679951A Medicinal composition for tumor body
10/12/2005CN1679950A Anticarcinogenic internal implant agent
10/12/2005CN1679949A Anticarcinogenic internal implant agent
10/12/2005CN1679948A Anticarcinogenic internal implant agent
10/12/2005CN1679947A Anticarcinogen composition
10/12/2005CN1679946A Anticarcinogen composition
10/12/2005CN1679945A Anticarcinogen composition
10/12/2005CN1679944A Anticarcinogen composition
10/12/2005CN1679943A Compound medicine for improving effect of ACEI hypotensor
10/12/2005CN1679942A Compound preparation of aspirin and ginkgo biloba extract and use thereof
10/12/2005CN1679941A Compound preparation consisting of taurine and medicines for hepatopathy and production thereof
10/12/2005CN1679940A Compound preparation of taurine and medicines for protecting liver and its making method
10/12/2005CN1679939A Medicinal composition for contraception and its usage
10/12/2005CN1679937A Compositions and methods for treating or preventing inflammatory diseases
10/12/2005CN1679936A Anticarcinogen composition
10/12/2005CN1679922A Gonadoliberin genital regulating medicine with double ways and reproduction of animals
10/12/2005CN1679921A Gonadoliberin genital regulating medicine with double ways and reproduction of fish
10/12/2005CN1679920A Gonadoliberin genital regulating medicine with double ways and reproduction of fishes, birds and animals
10/12/2005CN1679569A Stable extended release oral dosage composition
10/12/2005CN1679559A Cancer treatment
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679539A Synergic medicinal composition for preventing from tumor
10/12/2005CN1679518A Magnetic medicinal capsules and preparation thereof
10/12/2005CN1679515A Slow-releasing polymer microglobe of analgesic and preparation thereof
10/12/2005CN1679403A Fat or oil composition
10/12/2005CN1222617C Chemotactic factor receptos 88-2B [CKR-3] and 88C and their antibodies
10/12/2005CN1222522C Diphenyl azetidinone derivatives, method for prodn. thereof medicaments contg. these compounds, and their use
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 1151